The Boston Medical Center (BMC) Radiation Oncology Department has considerable experience in treating all types of cancers and benign tumors. Individual staff members concentrate on specific types of cancer so that patients can benefit from their specialized knowledge. BMC Radiation Oncologists are also actively involved in researching new and promising cancer treatments through clinical trials.
Broad Expertise from the Most Complex Cancers to Benign Tumors
Gastrointestinal (Gl) Cancer
Lisa Kachnic, MD, is a national leader in the treatment and research for colorectal, anal and other GI malignancies. The results from her latest study, which uses intensity modulated radiation to reduce the acute side effects of treating anal cancer, has just been reported at the annual meeting of the Amerixcan Society of Therapeutic Radiation Oncology (ASTRO).
BMC is participating in local and international trials evaluating partial breast irradiation (PBI) for women with early stage breast cancers. PBI offers a much shorter treatment time (typically one week) and potentially fewer side effects than the standard six weeks of whole breast treatment. As one of only a few institutions with the technology, we are the first in the region to utilize 3D Cone-Beam CT image guidance during treatments.
We are one of only a few centers in the United States using high-dose radiation prior to lung surgery. The goal is to eradicate as much tumor as possible, making it easier for the surgeon to remove any surviving cancer. In addition, we offer radioactive seed implantation and CyberkKnife® radiosurgery for patients who are not candidates for lobectomy.
Head and Neck Cancer
We are now actively studying the response of head and neck cancers to radiation therapy using novel functional imaging tools in combination with our advanced planning and treatment modalities.
In the management of prostate cancer, Radiation Oncology collaborates closely with surgeons from the department of Urology and the Robotic Prostatectomy program - the first in Boston. We were among the first institutions in the region to offer radioactive seed implantation as well; and we continue our advanced approach to care through the use of Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT) and prostate brachytherapy.
Working closely with BMC’s Neurosurgery department, we were one of the first local facilities to offer Stereotactic Radiosurgery (SRS). Our state-of-the-art facility also provides frameless Stereotactic Radiotherapy (SRT) with image guided delivery and now the new Cyberknife® robotic treatment delivery system. Our experience and advanced equipment allows us to provide comprehensive care for a full variety of malignant and benign brain lesions.
Radiation Oncology is an integral component of BMC’s national Amyloid Center.
Because clinical trials offer the most up-to-date treatment available, patients who participate in a clinical trial may benefit from the newest research. Many patients derive comfort from knowing that the knowledge gained will make an important contribution to medical science and may help other people with cancer.
For a list of currently active clinical studies, see our Hematology and Oncology clinical trials website at http://www.bumc.bu.edu/clinicaltrials/hematology-and-oncology-clinical-trials/.